AB Sciex Expands Operations in Singapore

November 7, 2013

LCGC Europe eNews

AB Sciex (Massachusetts, USA) has announced further expansion of its presence in Singapore, with the opening of a new research and development (R&D) centre. The centre is an addition to the company?s existing $10 million manufacturing operations in Marsiling, Singapore.

AB Sciex (Massachusetts, USA) has announced further expansion of its presence in Singapore, with the opening of a new research and development (R&D) centre. The centre is an addition to the company’s existing $10 million manufacturing operations in Marsiling, Singapore.

The centre is focused on bringing R&D and manufacturing together. The company has also invested in an application support and training facility in the “Biopolis” — Singapore’s biomedical research hub of public and private research activity. On the production side, manufacturing of selected chromatography products has already been transferred from the United States to Singapore.

Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board, said: “We are excited about the opening of AB Sciex’s R&D Centre in Singapore ‒ its first R&D centre outside North America. The centre will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB Sciex are looking to Singapore as an integrated home in Asia for complex instrument manufacturing [and] headquarter functions as well as R&D to support their future growth.”

Rainer Blair, President of AB Sciex, said: “Our significant investments in research and development, manufacturing, and personnel reaffirm our commitment to Singapore as a hub for AB Sciex global operations.” He added: “As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science.”

For more information please visit www.absciex.com

Related Content:

News